Submission Details
| 510(k) Number | K210130 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 19, 2021 |
| Decision Date | April 05, 2021 |
| Days to Decision | 76 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K210130 is an FDA 510(k) clearance for the Stockert S5 System, a Console, Heart-lung Machine, Cardiopulmonary Bypass (Class II — Special Controls, product code DTQ), submitted by Livanova Deutschland, GmbH (Munich, DE). The FDA issued a Cleared decision on April 5, 2021, 76 days after receiving the submission on January 19, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4220.
| 510(k) Number | K210130 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 19, 2021 |
| Decision Date | April 05, 2021 |
| Days to Decision | 76 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DTQ — Console, Heart-lung Machine, Cardiopulmonary Bypass |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.4220 |